Inventage Lab (XKRX:389470) Additional Paid-In Capital : ₩0.0 Mil(As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Additional Paid-In Capital?

Inventage Lab's quarterly additional paid-in capital increased from Sep. 2023 (₩44,220.3 Mil) to Dec. 2023 (₩44,600.1 Mil) but then stayed the same from Dec. 2023 (₩44,600.1 Mil) to Mar. 2024 (₩0.0 Mil).

Inventage Lab's annual additional paid-in capital increased from Dec. 2021 (₩29,534.7 Mil) to Dec. 2022 (₩43,462.3 Mil) and increased from Dec. 2022 (₩43,462.3 Mil) to Dec. 2023 (₩44,600.1 Mil).

Inventage Lab Additional Paid-In Capital Historical Data

The historical data trend for Inventage Lab's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Additional Paid-In Capital Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

54,916.28

29,534.73

43,462.32

44,600.10

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial					43,484.76	44,057.25	44,220.26	44,600.10	-

Inventage Lab Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Inventage Lab Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines